Top Banner
Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism
44
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and

Metabolism

Page 2: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Principles and Definitions

• Selectivity– Selectivtytoxicity

• Therapeutic index– Toxic dose/ Effective dose

• Categories of antibiotics– Bacteriostatic

• Duration of treatment sufficient for host defenses

– Bactericidal• Usually antibiotic of choice

Page 3: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Principles and Definitions

• Selectivity

• Therapeutic index• Categories of antibiotics

– Use of bacteriostatic vs bactericidal antibiotic• Therapeutic index better for bacteriostatic antibiotic

• Resistance to bactericidal antibiotic

• Protein toxin mediates disease – use bacteriostatic protein synthesis inhibitor

Page 4: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Principles and Definitions

• Antibiotic susceptibility testing (in vitro)– Minimum inhibitory concentration (MIC)

• Lowest concentration that results in inhibition of visible growth

– Minimum bactericidal concentration (MBC)• Lowest concentration that kills 99.9% of the original

inoculum

Page 5: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antibiotic Susceptibility Testing

8 4 02 1 Tetracycline (g/ml)

MIC = 2 g/ml

Determination of MIC

Chl Amp

Ery

Str

Tet

Disk Diffusion Test

Page 6: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Zone diameter (mm) Approx. MIC( g/ml) for:Antimicrobial agent

(amt. per disk)and organism R I MS S R S

Ampicillin (10 g)

Enerobacteriacae 11 12-13 14 32 8

Haemophilus spp. 19 20 4 2

Enterococci 16 17 16

Tetracycline (30 g) 14 15-18 19 16 4

Zone Diameter Standards for Disk Diffusion Tests

Page 7: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Principles and Definitions

• Combination therapy– Prevent emergence of resistant strains– Temporary treatment until diagnosis is made– Antibiotic synergism

• Penicillins and aminoglycosides

• CAUTION: Antibiotic antagonism– Penicillins and bacteriostatic antibiotics

• Antibiotics vs chemotherapeutic agents vs antimicrobials

Page 8: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antibiotics that Inhibit Protein Synthesis

Page 9: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Review of Initiation of Protein Synthesis

30S1 32 GTP

1 2 3 GTP

Initiation Factors

mRNA

3

1

2 GTP

30S Initiation Complex

f-met-tRNA

Spectinomycin

Aminoglycosides

12

GDP + Pi 50S

70S Initiation Complex

AP

Page 10: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Review of Elongation of Protein Synthesis

GTP

AP

Tu GTP Tu GDP

Ts

TsTu

+

GDPTs

Pi

P ATetracycline

AP

Erythromycin

Fusidic Acid

Chloramphenicol

G GTPG GDP + Pi

G

GDP

AP

+GTP

Page 11: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Protein Synthesis

Microbe Library -American Society for Microbiology

www.microbelibrary.org

Page 12: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Survey of Antibiotics

Page 13: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Protein Synthesis Inhibitors

• Mostly bacteriostatic

• Selectivity due to differences in prokaryotic and eukaryotic ribosomes

• Some toxicity - eukaryotic 70S ribosomes

Page 14: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antimicrobials that Bind to the 30S Ribosomal Subunit

Page 15: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Aminoglycosides (bactericidal)streptomycin, kanamycin, gentamicin, tobramycin,

amikacin, netilmicin, neomycin (topical)

• Mode of action - The aminoglycosides irreversibly bind to the 16S ribosomal RNA and freeze the 30S initiation complex (30S-mRNA-tRNA) so that no further initiation can occur. They also slow down protein synthesis that has already initiated and induce misreading of the mRNA. By binding to the 16 S r-RNA the aminoglycosides increase the affinity of the A site for t-RNA regardless of the anticodon specificity. May also destabilize bacterial membranes.

Page 16: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Microbe Library

American Society for Microbiology

www.microbelibrary.org

Page 17: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Aminoglycosides (bactericidal)streptomycin, kanamycin, gentamicin, tobramycin,

amikacin, netilmicin, neomycin (topical)

• Spectrum of Activity -Many gram-negative and some gram-positive bacteria; Not useful for anaerobic (oxygen required for uptake of antibiotic) or intracellular bacteria.

• Resistance - Common

• Synergy - The aminoglycosides synergize with -lactam antibiotics. The -lactams inhibit cell wall synthesis and thereby increase the permeability of the aminoglycosides.

Page 18: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Tetracyclines (bacteriostatic)tetracycline, minocycline and doxycycline

• Mode of action - The tetracyclines reversibly bind to the 30S ribosome and inhibit binding of aminoacyl-t-RNA to the acceptor site on the 70S ribosome.

• Spectrum of activity - Broad spectrum; Useful against intracellular bacteria

• Resistance - Common

• Adverse effects - Destruction of normal intestinal flora resulting in increased secondary infections; staining and impairment of the structure of bone and teeth.

Page 19: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Spectinomycin (bacteriostatic)

• Mode of action - Spectinomycin reversibly interferes with m-RNA interaction with the 30S ribosome. It is structurally similar to the aminoglycosides but does not cause misreading of mRNA.

• Spectrum of activity - Used in the treatment of penicillin-resistant Neisseria gonorrhoeae

• Resistance - Rare in Neisseria gonorrhoeae

Page 20: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antimicrobials that Bind to the 50S Ribosomal Subunit

Page 21: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Chloramphenicol, Lincomycin, Clindamycin (bacteriostatic)

• Mode of action - These antimicrobials bind to the 50S ribosome and inhibit peptidyl transferase activity.

• Spectrum of activity - Chloramphenicol - Broad range;Lincomycin and clindamycin -

Restricted range

• Resistance - Common

• Adverse effects - Chloramphenicol is toxic (bone marrow suppression) but is used in the treatment of bacterial meningitis.

Page 22: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Macrolides (bacteriostatic)erythromycin, clarithromycin, azithromycin, spiramycin

• Mode of action - The macrolides inhibit translocation.

• Spectrum of activity - Gram-positive bacteria, Mycoplasma, Legionella

• Resistance - Common

Page 23: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Microbe Library

American Society for Microbiology

www.microbelibrary.org

Page 24: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antimicrobials that Interfere with Elongation Factors

Selectivity due to differences in prokaryotic and eukaryotic elongation factors

Page 25: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Fusidic acid (bacteriostatic)

• Mode of action - Fusidic acid binds to elongation factor G (EF-G) and inhibits release of EF-G from the EF-G/GDP complex.

• Spectrum of activity - Gram-positive cocci

Page 26: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Inhibitors of Nucleic Acid Synthesis

Page 27: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Inhibitors of RNA Synthesis

Selectivity due to differences between prokaryotic and eukaryotic

RNA polymerase

Page 28: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Rifampin, Rifamycin, Rifampicin, Rifabutin (bactericidal)

• Mode of action - These antimicrobials bind to DNA-dependent RNA polymerase and inhibit initiation of mRNA synthesis.

• Spectrum of activity - Broad spectrum but is used most commonly in the treatment of tuberculosis

• Resistance - Common

• Combination therapy - Since resistance is common, rifampin is usually used in combination therapy.

Page 29: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Inhibitors of DNA Synthesis

Selectivity due to differences between prokaryotic and eukaryotic enzymes

Page 30: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Quinolones (bactericidal)nalidixic acid, ciprofloxacin, ofloxacin, norfloxacin,

levofloxacin, lomefloxacin, sparfloxacin

• Mode of action - These antimicrobials bind to the A subunit of DNA gyrase (topoisomerase) and prevent supercoiling of DNA, thereby inhibiting DNA synthesis.

• Spectrum of activity - Gram-positive cocci and urinary tract infections

• Resistance - Common for nalidixic acid; developing for ciprofloxacin

Page 31: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antimetabolite Antimicrobials

Page 32: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Inhibitors of Folic Acid Synthesis

• Basis of Selectivity

• Review of Folic Acid Metabolism

p-aminobenzoic acid + Pteridine

Dihydropteroic acid

Dihydrofolic acid

Tetrahydrofolic acid

Pteridine synthetase

Dihydrofolate synthetase

Dihydrofolate reductase

ThymidinePurines

Methionine

Trimethoprim

Sulfonamides

Page 33: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Sulfonamides, Sulfones (bacteriostatic)

• Mode of action - These antimicrobials are analogues of para-aminobenzoic acid and competitively inhibit formation of dihydropteroic acid.

• Spectrum of activity - Broad range activity against gram-positive and gram-negative bacteria; used primarily in urinary tract and Nocardia infections.

• Resistance - Common

• Combination therapy - The sulfonamides are used in combination with trimethoprim; this combination blocks two distinct steps in folic acid metabolism and prevents the emergence of resistant strains.

Page 34: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Trimethoprim, Methotrexate, Pyrimethamine (bacteriostatic)

• Mode of action - These antimicrobials binds to dihydrofolate reductase and inhibit formation of tetrahydrofolic acid.

• Spectrum of activity - Broad range activity against gram-positive and gram-negative bacteria; used primarily in urinary tract and Nocardia infections.

• Resistance - Common

• Combination therapy - These antimicrobials are used in combination with the sulfonamides; this combination blocks two distinct steps in folic acid metabolism and prevents the emergence of resistant strains.

Page 35: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Anti-Mycobacterial Antibiotics

Page 36: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Para-aminosalicylic acid (PSA) (bacteriostatic)

• Mode of action - Similar to sulfonamides

• Spectrum of activity - Specific for Mycobacterium tuberculosis

Page 37: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Dapsone (bacteriostatic)

• Mode of action - Similar to sulfonamides

• Spectrum of activity - Used in treatment of leprosy (Mycobacterium leprae)

Page 38: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antimicrobial Drug ResistancePrinciples and Definitions

• Clinical resistance vs actual resistance

• Resistance can arise by mutation or by gene transfer (e.g. acquisition of a plasmid)

• Resistance provides a selective advantage

• Resistance can result from single or multiple steps

• Cross resistance vs multiple resistance– Cross resistance -- Single mechanism-- closely related

antibiotics– Multiple resistance -- Multiple mechanisms -- unrelated

antibiotics

Page 39: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antimicrobial Drug ResistanceMechanisms

• Altered permeability– Altered influx

• Gram negative bacteria

Page 40: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Microbe Library

American Society for Microbiology

www.microbelibrary.org

Page 41: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antimicrobial Drug ResistanceMechanisms

• Altered permeability– Altered efflux

• tetracycline

Microbe Library

American Society for Microbiology

www.microbelibrary.org

Page 42: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antimicrobial Drug ResistanceMechanisms

• Inactivation -lactamase

– Chloramphenicol acetyl transferase

Microbe Library

American Society for Microbiology

www.microbelibrary.org

Page 43: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antimicrobial Drug ResistanceMechanisms

• Altered target site– Penicillin binding

proteins (penicillins)

– RNA polymerase (rifampin)

– 30S ribosome (streptomycin)

Microbe Library

American Society for Microbiology

www.microbelibrary.org

Page 44: Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.

Antimicrobial Drug ResistanceMechanisms

• Replacement of a sensitive pathway– Acquisition of a resistant

enzyme (sulfonamides, trimethoprim)